Metallo Bio
Sheffield
About Metallo Bio
Metallo Bio's focus is on the development of two lead chemicals that represent a pioneering new class of antibiotics, with the goal of addressing the rising issue of antimicrobial resistance.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $573.1K
- Funding stage: Seed
- Last round: Seed (Apr 2024)
- Website: metallobio.com
Industries & Categories
Biopharma, Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/metallo-bio-180387 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.